APA

de Mello N. R., Baracat E. C., Tomaz G., Bedone A. J., Camargos A., Barbosa I. C., de Souza R. N., Rumi D. O., Martinez Alcala F. O., Velasco J. A. A. & Cortes R. J. R. (20040802). Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea. : Acta obstetricia et gynecologica Scandinavica.

Chicago

de Mello Nilson Roberto, Baracat Edmund Chada, Tomaz Geraldez, Bedone Aloísio José, Camargos Aroldo, Barbosa Ione Cristina, de Souza Rosival Nassar, Rumi Demetrio Ortega, Martinez Alcala Felix Octavio, Velasco Jorge Antonio Aldrete and Cortes Roberto Jose Risco. 20040802. Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea. : Acta obstetricia et gynecologica Scandinavica.

Harvard

de Mello N. R., Baracat E. C., Tomaz G., Bedone A. J., Camargos A., Barbosa I. C., de Souza R. N., Rumi D. O., Martinez Alcala F. O., Velasco J. A. A. and Cortes R. J. R. (20040802). Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea. : Acta obstetricia et gynecologica Scandinavica.

MLA

de Mello Nilson Roberto, Baracat Edmund Chada, Tomaz Geraldez, Bedone Aloísio José, Camargos Aroldo, Barbosa Ione Cristina, de Souza Rosival Nassar, Rumi Demetrio Ortega, Martinez Alcala Felix Octavio, Velasco Jorge Antonio Aldrete and Cortes Roberto Jose Risco. Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea. : Acta obstetricia et gynecologica Scandinavica. 20040802.